ROXANE LABS EXTENDS PAIN CONTROL EDUCATION PROGRAM TO AIDS
ROXANE LABS EXTENDS PAIN CONTROL EDUCATION PROGRAM TO AIDS, and plans to select a center devoted to AIDS by mid-May that will form a part of the Company's newly announced Pain Institute. It will be the first of three AIDS and cancer treatment centers to be selected within 30-60 days. Each will provide training and information for health care professionals, patients and care givers on management of cancer and AIDS pain. Some centers may provide a blend of cancer and AIDS services. The treatment centers will be modeled on an existing Palliative Care Scholars Program focused on cancer that is funded by Roxane and administered by the Cleveland Clinic Foundation. Roxane will work with each center to develop a program curriculum.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth